Search research articles
Contact Us
Filters
Showing results (61-70 of 169) with videos related to
Page
of 17
Sort By:
Archives of Internal Medicine
|
September 12, 2007
Serious adverse drug events reported to the Food and Drug Administration, 1998-2005
Thomas J Moore, Michael R Cohen, Curt D Furberg
JAMA
|
April 13, 2006
Recent trials in hypertension: compelling science or commercial speech?
Bruce M Psaty, Noel S Weiss, Curt D Furberg
Current Controlled Trials in Cardiovascular Medicine
|
July 9, 2004
Balancing commercial and public interests
Curt D Furberg, Mark A Hall, Mary Ann Sevick
Journal of the American College of Cardiology
|
May 18, 2004
From knowledge to practice in chronic cardiovascular disease: a long and winding road
Sumit R Majumdar, Finlay A McAlister, Curt D Furberg
Circulation
|
January 19, 2005
Parecoxib, valdecoxib, and cardiovascular risk
Curt D Furberg, Bruce M Psaty, Garret A FitzGerald
Journal of Telemedicine and Telecare
|
May 17, 2014
A pilot test of a new tool for remote blood pressure monitoring
Kurt Boman, Andre Brenander, Mats Gustavsson, et al.
Postgraduate Medical Journal
|
March 20, 2014
Republished: pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications
Sonal Singh, Yoon K Loke, Paul Enright, et al.
Hypertension (Dallas, Tex. : 1979)
|
June 21, 2006
Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States
Randall S Stafford, Veronica Monti, Curt D Furberg, et al.
Circulation
|
August 6, 2008
Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study
Dariush Mozaffarian, Curt D Furberg, Bruce M Psaty, et al.
Thorax
|
July 6, 2012
Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications
Sonal Singh, Yoon K Loke, Paul Enright, et al.
Page
of 17
Search research articles
Search
Showing results (61-70 of 169) with videos related to
Sort By:
Page
of 17
Archives of Internal Medicine
|
September 12, 2007
Serious adverse drug events reported to the Food and Drug Administration, 1998-2005
Thomas J Moore, Michael R Cohen, Curt D Furberg
JAMA
|
April 13, 2006
Recent trials in hypertension: compelling science or commercial speech?
Bruce M Psaty, Noel S Weiss, Curt D Furberg
Current Controlled Trials in Cardiovascular Medicine
|
July 9, 2004
Balancing commercial and public interests
Curt D Furberg, Mark A Hall, Mary Ann Sevick
Journal of the American College of Cardiology
|
May 18, 2004
From knowledge to practice in chronic cardiovascular disease: a long and winding road
Sumit R Majumdar, Finlay A McAlister, Curt D Furberg
Circulation
|
January 19, 2005
Parecoxib, valdecoxib, and cardiovascular risk
Curt D Furberg, Bruce M Psaty, Garret A FitzGerald
Journal of Telemedicine and Telecare
|
May 17, 2014
A pilot test of a new tool for remote blood pressure monitoring
Kurt Boman, Andre Brenander, Mats Gustavsson, et al.
Postgraduate Medical Journal
|
March 20, 2014
Republished: pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications
Sonal Singh, Yoon K Loke, Paul Enright, et al.
Hypertension (Dallas, Tex. : 1979)
|
June 21, 2006
Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States
Randall S Stafford, Veronica Monti, Curt D Furberg, et al.
Circulation
|
August 6, 2008
Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study
Dariush Mozaffarian, Curt D Furberg, Bruce M Psaty, et al.
Thorax
|
July 6, 2012
Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications
Sonal Singh, Yoon K Loke, Paul Enright, et al.
Page
of 17